358 related articles for article (PubMed ID: 16120091)
1. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.
Diamant Z; Kuperus J; Baan R; Nietzmann K; Millet S; Mendes P; Miller B; Amin D; Rohatagi S; Sterk PJ; Hoogsteden HC; Prins JB
Clin Exp Allergy; 2005 Aug; 35(8):1080-7. PubMed ID: 16120091
[TBL] [Abstract][Full Text] [Related]
2. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
[TBL] [Abstract][Full Text] [Related]
3. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
Ravensberg AJ; Luijk B; Westers P; Hiemstra PS; Sterk PJ; Lammers JW; Rabe KF
Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513
[TBL] [Abstract][Full Text] [Related]
4. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
[TBL] [Abstract][Full Text] [Related]
5. The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects.
Diamant Z; Van der Veen H; Kuijpers EA; Bakker PF; Sterk PJ
Clin Exp Allergy; 1996 May; 26(5):525-32. PubMed ID: 8735864
[TBL] [Abstract][Full Text] [Related]
6. Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.
Boot JD; de Haas S; Tarasevych S; Roy C; Wang L; Amin D; Cohen J; Sterk PJ; Miller B; Paccaly A; Burggraaf J; Cohen AF; Diamant Z
Am J Respir Crit Care Med; 2007 Mar; 175(5):450-7. PubMed ID: 17170385
[TBL] [Abstract][Full Text] [Related]
7. Sputum inflammatory cells and allergen-induced airway responses in allergic asthmatic subjects.
Imaoka H; Gauvreau GM; Watson RM; Strinich T; Obminksi GL; Howie K; Killian KJ; O'Byrne PM
Allergy; 2011 Aug; 66(8):1075-80. PubMed ID: 21447082
[TBL] [Abstract][Full Text] [Related]
8. Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.
Louw C; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbroker D; Bardin PG
Respiration; 2007; 74(4):411-7. PubMed ID: 16954654
[TBL] [Abstract][Full Text] [Related]
9. Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment.
van Rensen EL; Evertse CE; van Schadewijk WA; van Wijngaarden S; Ayre G; Mauad T; Hiemstra PS; Sterk PJ; Rabe KF
Allergy; 2009 Jan; 64(1):72-80. PubMed ID: 19076931
[TBL] [Abstract][Full Text] [Related]
10. The allergen specificity of the late asthmatic reaction.
Hatzivlassiou M; Grainge C; Kehagia V; Lau L; Howarth PH
Allergy; 2010 Mar; 65(3):355-8. PubMed ID: 19804443
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
12. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses.
Gauvreau GM; Hessel EM; Boulet LP; Coffman RL; O'Byrne PM
Am J Respir Crit Care Med; 2006 Jul; 174(1):15-20. PubMed ID: 16574937
[TBL] [Abstract][Full Text] [Related]
13. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
[TBL] [Abstract][Full Text] [Related]
14. Allergen inhalation challenge in smoking compared with non-smoking asthmatic subjects.
Meghji Z; Dua B; Watson RM; Gauvreau GM; O'Byrne PM
Clin Exp Allergy; 2011 Aug; 41(8):1084-90. PubMed ID: 21631611
[TBL] [Abstract][Full Text] [Related]
15. Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon.
Marcucci F; Passalacqua G; Canonica GW; Frati F; Salvatori S; Di cara G; Petrini I; Bernini M; Novembre E; Bernardini R; Incorvaia C; Sensi LG
Respir Med; 2007 Jul; 101(7):1600-8. PubMed ID: 17482451
[TBL] [Abstract][Full Text] [Related]
16. Low-dose endotoxin in allergic asthmatics: effect on bronchial and inflammatory response to cat allergen.
Sohy C; Pons F; Casset A; Chesnard MP; Lieutier-Colas F; Meyer P; Pauli G; de Blay F
Clin Exp Allergy; 2006 Jun; 36(6):795-802. PubMed ID: 16776681
[TBL] [Abstract][Full Text] [Related]
17. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.
Diamant Z; Sidharta PN; Singh D; O'Connor BJ; Zuiker R; Leaker BR; Silkey M; Dingemanse J
Clin Exp Allergy; 2014 Aug; 44(8):1044-52. PubMed ID: 24964348
[TBL] [Abstract][Full Text] [Related]
18. The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge.
Duong M; Gauvreau G; Watson R; Obminski G; Strinich T; Evans M; Howie K; Killian K; O'Byrne PM
J Allergy Clin Immunol; 2007 Feb; 119(2):322-7. PubMed ID: 17141859
[TBL] [Abstract][Full Text] [Related]
19. Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy.
Subbarao P; Dorman SC; Rerecich T; Watson RM; Gauvreau GM; O'Byrne PM
J Allergy Clin Immunol; 2005 Apr; 115(4):745-50. PubMed ID: 15805993
[TBL] [Abstract][Full Text] [Related]
20. The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity.
Bruce C; Thomas PS
Toxicol Appl Pharmacol; 2005 Jun; 205(2):126-32. PubMed ID: 15893540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
